Description
Adiponectin Antibody [MADI 1147] | 36-002 | Gentaur UK, US & Europe Distribution
Host: Mouse
Reactivity: Mouse
Homology: N/A
Immunogen: Recombinant mouse adiponectin.
Research Area: Obesity
Tested Application: E, IP, WB
Application: ELISA: (direct and indirect: 1:5, 000-1:10, 000) . Immunoprecipitation: (1-5ug per sample in a final reaction volume of 500-1000ul) . Western blot: (1:5, 000-1:10, 000 using ECL; suggested blocking and dilution buffer is TBST containing 0.05% Tween 20 and 5% skim milk; suggested incubation time is 1 hour at room temperature) . Optimal conditions must be determined individually for each application.
Specificiy: Recognizes mouse adiponectin. Detects a band of ~30kDa by Western blot. Weakly cross-reacts with human and rat adiponectin.
Positive Control 1: N/A
Positive Control 2: N/A
Positive Control 3: N/A
Positive Control 4: N/A
Positive Control 5: N/A
Positive Control 6: N/A
Molecular Weight: N/A
Validation: N/A
Isoform: N/A
Purification: N/A
Clonality: Monoclonal
Clone: MADI 1147
Isotype: IgG1, kappa
Conjugate: Unconjugated
Physical State: Liquid
Buffer: Liquid. 0.2um-filtered solution in PBS, pH 7.4. Contains no preservatives.
Concentration: 1 mg/ml
Storage Condition: Stable for at least 1 year after receipt when stored at -20˚C.
Alternate Name: ACRP30; AdipoQ; apM1; GBP28; Adipocyte Complement Related Protein of 30kDa
User Note: Optimal dilutions for each application to be determined by the researcher.
BACKGROUND: ACRP30 was identified as a novel adipocyte-specific synthesized and secreted protein with structural resemblance to complement factor C1q. Like adipsin, ACRP30 secretion is induced ~10-fold during adipocyte differentiation. Plasma levels are reduced in obese humans, and low levels are associated with insulin-resistance. Treatment of db/db mice with TZD increased ACRP30 levels.